Further Growth of Existing Core Businesses
First written in FY2017-Q1. 30 of 37 entries say "Advanced", first in FY2017. Latest entry: 2026-08-14.
No other company in this theme has enough history to compare yet.
- 2026-08-14AdvancedEarnings
「In our core CTI business, acquisition of recurring-revenue projects based on subscriptions progressed steadily, while we also secured a certain number of high-margin project-based contracts. In addition, subscription-based recurring revenue was generally acquired smoothly in the other businesses,」
Acquisition of recurring-revenue and project-based CTI contracts, together with recurring subscription revenue in the other businesses, contributed to higher revenue and profit. - FY2026AdvancedAnnual report
「In BSR1, the first growth engine, the CTI, VoXT and Medical divisions increased revenue, resulting in a 4.6% year-on-year increase.」
BSR1 posted a 4.6% year-on-year increase in revenue, driven by higher revenue from the CTI, VoXT and Medical Business Units. - 2026-05-13AdvancedRevision of earnings forecasts
「In BSR1, the first growth engine, the CTI, VoXT and Medical divisions increased revenue, resulting in a 4.6% year-on-year increase.」
All 3 divisions of the existing core business increased revenue, driving overall growth in BSR1. - FY2026-H1Increase in recurring revenue and decline in transactional salesAnnual report
「Revenue in BSR1 (the first growth engine) declined 2.5% year on year, as all business units steadily increased recurring subscription usage and recurring revenue, but revenue from transactional sales in the CTI Business Unit declined.」
In BSR1, recurring subscription usage and recurring revenue increased, but total revenue declined 2.5% year on year due to a decline in CTI's transactional sales. - FY2025AdvancedAnnual report
「In BSR1 (the first growth engine), all business units posted higher revenue, resulting in an 11.0% year-on-year increase in revenue,」
BSR1, the existing core business, posted an 11.0% year-on-year increase in revenue, with all business units posting higher revenue. - FY2025-H1AdvancedAnnual report
「In BSR1 (the first growth engine), all business units posted higher revenue as the revenue mix improved, including through an increase in recurring revenue, resulting in a 10.5% year-on-year increase in revenue,」
All BSR1 business units posted higher revenue, resulting in a 10.5% year-on-year increase. The disclosure also noted a qualitative improvement in the revenue structure driven by increased recurring revenue. - FY2024AdvancedAnnual report
「Revenue in BSR1 (the first growth engine) increased 18.2% year on year, as the CTI, VoXT and Medical Business Units posted higher revenue.」
BSR1, the existing core business, posted revenue of ¥5,357 million, up 18.2% year on year, driven by higher revenue from the CTI, VoXT and Medical Business Units. - FY2024-Q3AdvancedAnnual report
「Revenue in BSR1 (the first growth engine) increased 24.6% year on year, as the CTI, VoXT and Medical Business Units posted higher revenue,」
BSR1, the existing core business, posted a 24.6% year-on-year increase in revenue, driven by higher revenue from the CTI, VoXT and Medical Business Units. - FY2024-Q2AdvancedAnnual report
「In BSR1 (the first growth engine), the CTI, VoXT and Medical Business Units posted higher revenue, resulting in a 27.2% year-on-year increase.」
BSR1, the existing core business, posted a 27.2% year-on-year increase in revenue, driven by higher revenue from the CTI, VoXT and Medical Business Units. - FY2024-Q1AdvancedAnnual report
「In BSR1 (the first growth engine), the CTI, VoXT and Medical Business Units posted higher revenue, resulting in a 14.2% year-on-year increase.」
BSR1, the existing core business, posted a 14.2% year-on-year increase in revenue, driven by higher revenue from the CTI, VoXT and Medical Business Units. - FY2023-Q3AdvancedAnnual report
「Revenue in BSR1 (the first growth engine) increased 15.7% year on year, as the CTI and VoXT Business Units posted higher revenue,」
BSR1, the existing core business, posted a 15.7% year-on-year increase in revenue, driven by higher revenue from the CTI and VoXT Business Units. - FY2023-Q2AdvancedAnnual report
「BSR1 (the first growth engine) ¥2,053 million Up 19.4% ¥486 million Up 54.6%」
BSR1, the existing core business, posted a 19.4% year-on-year increase in revenue and a 54.6% increase in operating profit. - FY2023-Q1AdvancedAnnual report
「Revenue in BSR1 (the first growth engine) increased 17.6% year on year, driven by a substantial increase in revenue from the CTI Business Unit.」
In BSR1, the existing core business, revenue from the CTI Business Unit increased 17.6% year on year, while operating profit also increased 63.0%. - FY2022AdvancedAnnual report
「BSR1 (the first growth engine) ¥3,924 million Up 3.3% ¥920 million Up 4.3%」
BSR1, the existing core business, posted revenue of ¥3,924 million, up 3.3% year on year, and operating profit of ¥920 million, up 4.3%. - FY2022-Q3AdvancedAnnual report
「Revenue in BSR1 (the first growth engine) increased 10.0% year on year, as the VoXT and Medical Business Units posted higher revenue.」
BSR1 revenue increased 10.0% year on year, driven by higher revenue from the VoXT and Medical Business Units. - FY2022-Q2AdvancedAnnual report
「Revenue in BSR1 (the first growth engine) increased 9.5% year on year, as the VoXT and Medical Business Units posted higher revenue.」
BSR1 revenue increased 9.5% year on year, driven by higher revenue from the VoXT and Medical Business Units. Operating profit also increased 49.3% year on year, indicating growth in the existing core business. - FY2022-Q1AdvancedAnnual report
「Revenue in BSR1 (the first growth engine) increased 11.1% year on year, as the VoXT and Medical Business Units posted substantial revenue growth,」
BSR1 revenue increased 11.1% year on year, driven by higher revenue from the VoXT and Medical Business Units, while operating profit also increased 80.9% year on year to ¥104 million. - FY2021Revenue Up, Profit DownAnnual report
「BSR1 (the first growth engine) ¥3,799 million Up 2.2% ¥883 million Down 11.1%」
All BSR1 business units posted higher revenue, resulting in a 2.2% increase from the previous period, while operating profit was ¥883 million, down 11.1% from the previous period. - FY2021-Q3Lower revenue and profit, with a recovery in some businessesAnnual report
「Revenue in BSR1 (the first growth engine) was almost unchanged from the same period of the previous year and showed a recovery trend on a quarterly basis. However, revenue declined year on year because the Medical Business Unit and consolidated subsidiary AMIVOICE THAI CO., LTD. (Thailand) posted substantial revenue declines due to the impact of COVID-19, and because sales previously recorded by 株式会社グラモ, which had been part of the consolidated group in the previous period, were no longer recorded.」
BSR1 overall posted an 8.4% year-on-year decline in revenue, while operating profit fell 44.7%. The company also described a recovery trend on a quarterly basis. - FY2021-Q2Lower revenue and profit, with progress in shifting to recurring revenueAnnual report
「As a result, revenue in BSR1 (the first growth engine) declined, despite higher recurring-revenue ratios across all business units and progress in introducing subscription services, due to a sharp decline in business meetings with medical institutions in the Medical Business Unit, compounded by the impact of the large license revenue recorded by the CTI Business Unit in the same period of the previous year.」
In BSR1, recurring-revenue ratios and subscription adoption increased across the business units, but revenue declined because of fewer business meetings with medical institutions and the reversal of the large license revenue recorded in the same period of the previous year. - FY2021-Q1AdvancedAnnual report
「As a result, revenue in BSR1 (the first growth engine) increased 2.5% year on year, as the CTI Business Unit posted higher revenue, while revenue declined in the Medical Business Unit because sales activities targeting medical institutions were restricted.」
BSR1, which represents the existing core business, posted a 2.5% year-on-year increase in revenue overall, despite a decline in revenue from the Medical Business Unit. - FY2020AdvancedAnnual report
「Revenue in BSR1 increased 19.3% from the previous period, as both the CTI and VoXT Business Units posted substantial revenue growth.」
BSR1, the existing core business, posted a 19.3% increase in revenue from the previous period and operating profit of ¥993 million, up 4.1%, indicating progress in growth and in strengthening its earnings structure. - FY2020-Q3AdvancedAnnual report
「As a result, revenue in BSR1 (the first growth engine) increased 30.4% year on year, as both the CTI and VoXT Business Units posted substantial revenue growth.」
In BSR1, which represents the existing core business, revenue increased 30.4% year on year as both the CTI and VoXT Business Units posted revenue growth. - FY2020-Q2AdvancedAnnual report
「As a result, revenue in BSR1 (the first growth engine) increased 35.0% year on year, mainly due to a substantial increase in revenue from the CTI Business Unit.」
BSR1, which represents the existing core business, increased 35.0% year on year, driven mainly by a substantial increase in revenue from the CTI Business Unit. - FY2020-Q1AdvancedAnnual report
「As a result, revenue from BSR1, the first growth engine, increased 21.0% year on year, with every business delivering revenue growth.」
All businesses in BSR1, which corresponds to the existing core businesses, delivered revenue growth, and revenue increased 21.0% year on year. - FY2019AdvancedAnnual report
「In BSR1, the first growth engine, revenue increased 13.8% year on year, driven by higher revenue in the CTI and VoXT divisions.」
BSR1, the existing core business, increased revenue 13.8% year on year due to higher revenue in the CTI and VoXT divisions, while operating profit increased 23.2%. - FY2019-Q3AdvancedAnnual report
「Revenue from BSR1, the first growth engine, increased 14.4% year on year, with all divisions performing solidly, led by the VoXT division.」
BSR1, which corresponds to the existing core businesses, performed solidly across all divisions, led by the VoXT division, and revenue increased 14.4% year on year. - FY2019-Q2AdvancedAnnual report
「Revenue from BSR1, the first growth engine, increased 11.3% year on year, with solid performance in the CTI and VoXT divisions.」
BSR1, which corresponds to the existing core businesses, increased revenue 11.3% year on year, led by the CTI and VoXT divisions, and all BSR1 divisions turned profitable. - FY2019-Q1AdvancedAnnual report
「BSR1, the first growth engine, increased 39.5% year on year, supported by solid performance in the CTI and VoXT divisions.」
BSR1, which corresponds to the existing core businesses, increased revenue 39.5% year on year, led by the CTI and VoXT divisions, and turned profitable. - FY2018AdvancedAnnual report
「BSR1 increased revenue 34.1% year on year and operating profit 8.8-fold, delivering substantial profit growth in addition to revenue growth.」
BSR1, which corresponds to the existing core businesses, increased revenue 34.1% year on year and operating profit 8.8-fold, achieving substantial profit growth in addition to revenue growth. - FY2018-Q3AdvancedAnnual report
「This was because BSR1, which accounts for most of revenue, increased 46.8% year on year. In particular, the CTI Division in BSR1’s call-center business made a significant contribution, increasing 123.5% year on year.」
BSR1, which corresponds to the existing core businesses, increased 46.8% year on year, while the CTI Division grew significantly by 123.5%. - FY2018-Q2AdvancedAnnual report
「Every division in the first growth engine (BSR1) and second growth engine (BSR2) exceeded the previous year’s results, and revenue increased 56.1% year on year. This was mainly due to BSR1, which accounts for most of revenue, expanding 47.8% year on year, and Gramo Co., Ltd., part of BSR2, expanding 189.7% year on year.」
Every division, including BSR1, which corresponds to the existing core businesses, exceeded the previous year’s results, and total revenue increased 56.1% year on year. - FY2018-Q1AdvancedAnnual report
「Revenue increased 35.1% year on year, and every division in both the first and second growth engines exceeded the initial plan. This was attributable to the growing use of speech-recognition technology as awareness of operational efficiency, represented by work-style reform, increased in each field, as well as the gradual increase in the proportion of recurring-service revenue through the monthly billing model for cloud services and the expansion of the services business pursued by the Group.」
Every division, including the first growth engine, exceeded the initial plan, and revenue increased 35.1% year on year. - FY2017AdvancedAnnual report
「Revenue from the first growth engine was broadly in line with the initial plan and increased 11.2% year on year.」
Revenue from the existing core businesses was broadly in line with the initial plan and increased 11.2% year on year. - FY2017-Q3RestatedAnnual report
「“Further growth of existing core businesses” as the first growth engine」
The Group continues to position its existing core businesses as its first growth engine. - FY2017-Q2RestatedAnnual report
「“Further growth of existing core businesses” as the first growth engine」
The Group continues to position its existing core businesses as its first growth engine. - FY2017-Q1First statedAnnual report
「“Further growth of existing core businesses” as the first growth engine」
The Group has positioned its existing speech business as its first growth engine.